Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Beckley Psytech

Recent news which mentions Beckley Psytech

Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Tickers ATAI DMT MDMA NEWS
Tags ATAI Psychedelics Research News
From Benzinga
Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
Tickers NEWS
Tags Beckley Psytech Psychedelics major depressive disorder
From Benzinga
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
Tickers NEWS
Tags psychedelics study 5/MeO/DMT Beckley Psytech Ltd
From Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
Tickers NEWS
Tags News BPL/003 Market News
From Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
Tags alcohol use disorder Psychedelics Beckley Psytech
From Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
Tags Beckley Psytech Psychedelics 5/MeO/DMT
From Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
Tags Market News Markets Cannabis
From Benzinga
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
Tags News Cosmo Feilding Mellen Psychedelics
From Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
Tags News Multidisciplinary Association for Psychedelic Studies Tim Schlidt
From Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
Tags 5/MeO/DMT News Beckley Psytech
From Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
Tickers CLABF MYCOF SILFF
Tags Cosmo Feilding Mellen SILFF Beckley Psytech
From Benzinga
Beckley Psytech Reaches $100M Financing To Study 5-MeO-DMT, Psilocybin And Other Psychedelics
Tags Cannabis Markets Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS